Form 4: ANI Pharmaceuticals SVP & CFO Stephen P. Carey Reports Tax-Related Stock Disposal
SEC Form 4 Filing
Stephen P. Carey, SVP & CFO of ANI Pharmaceuticals, reported the disposal of 4,534 shares of common stock to cover tax obligations related to vesting restricted stock.
Summary
- On April 10, 2024, Stephen P. Carey, the SVP & CFO of ANI Pharmaceuticals, disposed of 4,534 shares of common stock.
- The transaction was executed to cover tax obligations related to the vesting of 9,942 shares of restricted stock.
- The shares were disposed of at a price of $66.96 per share.
- Following the transaction, Carey directly owns 166,968 shares of ANI Pharmaceuticals common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the filing reflects a routine transaction for tax purposes, which is a normal part of executive compensation.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor potential alignment or misalignment of interests between management and shareholders.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a standard procedure for covering tax obligations.
Key Dates
| Date | Description |
|---|---|
| 04/10/2024 | Date of stock disposal |
| 04/11/2024 | Date of Form 4 signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.